Acellular Pertussis Completed Phase 4 Trials for Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)

IndicationStatusPhase
DBCOND0031302 (Acellular Pertussis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00548171Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058Prevention
NCT01147900Evaluation of Boostrix™10 Years After Previous Booster VaccinationPrevention
NCT01294605Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)Prevention